In fact, our previous studies, along with the current findings, demonstrate that genetic ablation or pharmacological inhibition of MT1-MMP confers protection against multiple age-associated disorders, including cognitive decline, obesity, and diabetes, without adverse effects15–17. This evidence concerns the gene MMP14 and obesity disorder.